Clinical trials
Phase 3 Endometrial Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| BioNTech SE | 1 |
| Genmab | 1 |
| Gilead Sciences | 1 |
| Queensland Centre for Gynaecological Cancer | 1 |
| Radiation Therapy Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 10 |
| Neoplasm Metastasis | 2 |
| Uterine Neoplasms | 2 |
| Postoperative Complications | 1 |
| Radiation Injuries | 1 |
| Recurrence | 1 |
| Uterine Cervical Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.